Bladder Cancer Surveillance
What is Bladder Cancer Surveillance?
Bladder cancer surveillance refers to the ongoing monitoring and follow-up process used to detect whether bladder cancer has returned or progressed after initial treatment. Because bladder cancer, particularly non-muscle-invasive bladder cancer (NMIBC), has a tendency to recur in some patients, regular surveillance is an important part of long-term care.
Surveillance involves a combination of investigations, including cystoscopy, urine tests, imaging, and clinical reviews. The exact schedule depends on factors such as the type of bladder cancer, tumour grade, stage, previous treatments, and individual risk of recurrence.
What are the Benefits of Bladder Cancer Surveillance?
Regular monitoring helps identify changes in the bladder at an early stage.
Benefits include:
- Detects recurrent bladder cancer early
- Allows prompt treatment when abnormalities are found
- Monitors response after bladder cancer treatment
- Helps assess the risk of disease progression
- Reduces delays in managing recurrent tumours
- Provides reassurance through structured follow-up
- Allows treatment plans to be adjusted based on changes over time
When is Bladder Cancer Surveillance Recommended?
Bladder cancer surveillance is recommended for most patients after treatment for bladder cancer, particularly those with non-muscle-invasive disease.
Surveillance may be recommended after:
- Transurethral resection of bladder tumour (TURBT)
- Intravesical treatments such as BCG therapy or chemotherapy
- Treatment for low-risk bladder tumours
- Treatment for intermediate or high-risk bladder cancer
- Partial cystectomy in selected patients
- Management of recurrent bladder tumours
The frequency and duration of surveillance depend on the risk category of the cancer. Patients with higher-risk tumours generally require more frequent monitoring.
What does Preparation for Bladder Cancer Surveillance Involve?
Preparation depends on which surveillance tests are required during your appointment.
Preparation may include:
- Review of your bladder cancer history and previous treatments
- Assessment of urinary symptoms
- Urine sample collection
- Blood tests if required
- Imaging preparation, such as drinking fluids before certain scans
- Discussion of current medications
- Review of any new symptoms, including blood in the urine, pain, or changes in urinary habits
Your urologist will explain the purpose of each test and what to expect during your surveillance programme.
How is Bladder Cancer Surveillance Performed?
Bladder cancer surveillance typically involves regular cystoscopy, which allows the inside of the bladder to be examined directly.
During cystoscopy, a thin flexible camera is passed through the urethra into the bladder after local anaesthetic gel is applied. The urologist examines the bladder lining for any abnormal areas, such as new tumours, inflammation, or suspicious lesions. The procedure usually takes only a few minutes and is commonly performed in an outpatient clinic.
Urine tests may also be used as part of surveillance. These can include urine cytology, which examines urine samples for abnormal cells, and other specialised urine marker tests in selected cases.
Imaging investigations, such as CT scans or ultrasound, may be recommended depending on the type and stage of bladder cancer. These scans can assess the upper urinary tract, including the kidneys and ureters, where cancer can occasionally develop.
If a suspicious area is identified during surveillance, your urologist may recommend further investigation, such as biopsy or repeat TURBT, to confirm the diagnosis and guide treatment.
What to Expect during Recovery after Bladder Cancer Surveillance?
Most surveillance procedures are minimally invasive and require little or no recovery time.
After cystoscopy, you may experience:
- Mild burning when passing urine
- Increased urinary frequency for a short period
- Small amounts of blood in the urine
- Mild bladder discomfort
These symptoms usually improve within a day or two. Drinking plenty of fluids may help reduce irritation after the procedure.
If further treatment is required following surveillance findings, your urologist will discuss the available options and next steps.
What are the Risks and Complications of Bladder Cancer Surveillance?
Bladder cancer surveillance is generally safe, but some investigations may carry minor risks.
Possible complications include:
- Temporary discomfort during cystoscopy
- Urinary tract infection
- Blood in the urine
- Bladder irritation
- Anxiety related to repeated testing
- False-positive results requiring additional investigations
- False-negative results, although uncommon
- Risks associated with imaging contrast agents in selected patients
Your urologist will create a personalised surveillance plan based on your bladder cancer diagnosis, previous treatments, and individual risk factors. Regular follow-up provides the best opportunity to identify recurrence early and ensure appropriate treatment is provided when needed.